Výsledky vyhledávání - "Caroline Dorrepaal"

Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients

Autor: Andrew Gammie, Caroline Dorrepaal, Satoshi Yoshida, Paul Abrams, Ton Kos, Achim Steup, Mathilde Kaper

Publikováno v: Neurourology and Urodynamics. 37:1501-1505

Aims This study aimed to identify signs and symptoms which show differences between men with detrusor underactivity (DU) compared to those with both DU and bladder outlet obstruction (BOO). Methods One thousand six hundred and twelve urodynamic tests

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e40d5d26abd580c98c299e3cd436cc4
https://doi.org/10.1002/nau.23492

Zobrazit plný text záznamu

Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017

Autor: Caroline Dorrepaal, Ralf Anding, Christopher Harding, Paul Abrams, Apostolos Apostolidis, Kevin Rademakers, Bertil F.M. Blok, Salvador Arlandis, Jalesh N. Panicker, Tom Marcelissen

Publikováno v: NEUROUROLOGY AND URODYNAMICS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Neurourology and Urodynamics, 37, S75-S85. Wiley
Neurourology and Urodynamics, 37, S75-S85. Wiley-Liss Inc.

AimsUrinary retention in women is poorly understood, compared to the equivalent condition in men, and was the subject of a dedicated session organized at the International Consultation on Incontinence Research Society (ICI-RS) in Bristol, United King

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fac40b927f00fe7ad327268db27749f
https://hdl.handle.net/1765/109664

Zobrazit plný text záznamu

What are the additional signs and symptoms in patients with detrusor underactivity and coexisting detrusor overactivity?

Autor: Andrew Gammie, Mathilde Kaper, Caroline Dorrepaal, Satoshi Yoshida, Ton Kos, Achim Steup, Paul Abrams

Publikováno v: Neurourology and urodynamics. 37(7)

Aims This study aimed to determine what difference the inclusion of patients with coexisting detrusor overactivity (DO) makes to the signs and symptoms of patients with detrusor underactivity (DU). Methods A total of 250 male and 435 female urodynami

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49eff266c8836ec47bdcd957242666d7
https://pubmed.ncbi.nlm.nih.gov/29635760

Zobrazit plný text záznamu

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

Autor: Javier Cambronero, Sender Herschorn, Mary Beth Blauwet, Victor W. Nitti, Caroline Dorrepaal, Javier C. Angulo, P. Van Kerrebroeck, Emad Siddiqui, N. E. Martin, Vikram Khullar

Publikováno v: International Journal of Clinical Practice, 67(7), 619-632. Wiley
International Journal of Clinical Practice

Introduction To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::985bf6cea12397bc504a730b855ca64b
https://doi.org/10.1111/ijcp.12194

Zobrazit plný text záznamu

Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder

Autor: Christopher R. Chapple, Caroline Dorrepaal, Jiri Klecka, Steven A. Kaplan, T. Drogendijk, Nancy Martin, Jana Cummings, David Mitcheson

Publikováno v: European Urology. 63:296-305

Background Despite several antimuscarinic treatment options for overactive bladder (OAB), there is still a need for distinct treatment approaches to manage this condition. Mirabegron, a β 3 -adrenoceptor agonist, has demonstrated efficacy and tolera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::719f8dd181a88e09ba986f508ae9e860
https://doi.org/10.1016/j.eururo.2012.10.048

Zobrazit plný text záznamu

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

Autor: Vik Khullar, Caroline Dorrepaal, Marianne Wooning, Javier C. Angulo, Javier Cambronero, Nancy Martin, Mary Beth Blauwet

Publikováno v: BMC Urology

Background Antimuscarinic agents are currently the predominant treatment option for the clinical management of the symptoms of overactive bladder (OAB). However, low rates of persistence with these agents highlight the need for novel, effective and b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82fd397eb7dfa7a7104868b6c8f3297f
https://doi.org/10.1186/1471-2490-13-45

Zobrazit plný text záznamu

Social Lifestyle, Risk-taking Behavior, and Psychopathology in Young Adults Born Very Preterm or with a Very Low Birthweight

Autor: Elysée T M, Hille, Caroline, Dorrepaal, Rom, Perenboom, Jack Bennebroek, Gravenhorst, Ronald, Brand, S Pauline, Verloove-Vanhorick, G J, van Steenbrugge

Publikováno v: Journal of pediatrics, 152(6). Mosby Inc.
Journal of Pediatrics, 6, 152

Objective: To assess social lifestyle, risk-taking behavior, and psychopathology in young adults born very preterm or with a very low birthweight. Study design: This study was part of the 19-year follow-up in a large ongoing collaborative study in th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e824362fa90b8c9557a3af6267f5bf6
http://resolver.tudelft.nl/uuid:ab9e403a-3a90-4fb3-b884-b0c5699675c2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání